245 related articles for article (PubMed ID: 33918477)
1. The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.
Werner H; Sarfstein R; Laron Z
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33918477
[TBL] [Abstract][Full Text] [Related]
2. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
3. Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction.
Sarfstein R; Werner H
Endocrinology; 2013 May; 154(5):1672-9. PubMed ID: 23507573
[TBL] [Abstract][Full Text] [Related]
4. The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities.
Werner H
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834331
[TBL] [Abstract][Full Text] [Related]
5. Identification of nucleolar protein NOM1 as a novel nuclear IGF1R-interacting protein.
Solomon-Zemler R; Pozniak Y; Geiger T; Werner H
Mol Genet Metab; 2019 Mar; 126(3):259-265. PubMed ID: 30639046
[TBL] [Abstract][Full Text] [Related]
6. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H
Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384
[TBL] [Abstract][Full Text] [Related]
7. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.
Chen J; Nagle AM; Wang YF; Boone DN; Lee AV
J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor and IGF1R are not required for oocyte growth, differentiation, and maturation in mice.
Pitetti JL; Torre D; Conne B; Papaioannou MD; Cederroth CR; Xuan S; Kahn R; Parada LF; Vassalli JD; Efstratiadis A; Nef S
Sex Dev; 2009; 3(5):264-72. PubMed ID: 19851056
[TBL] [Abstract][Full Text] [Related]
9. Inceptor counteracts insulin signalling in β-cells to control glycaemia.
Ansarullah ; Jain C; Far FF; Homberg S; Wißmiller K; von Hahn FG; Raducanu A; Schirge S; Sterr M; Bilekova S; Siehler J; Wiener J; Oppenländer L; Morshedi A; Bastidas-Ponce A; Collden G; Irmler M; Beckers J; Feuchtinger A; Grzybek M; Ahlbrecht C; Feederle R; Plettenburg O; Müller TD; Meier M; Tschöp MH; Coskun Ü; Lickert H
Nature; 2021 Feb; 590(7845):326-331. PubMed ID: 33505018
[TBL] [Abstract][Full Text] [Related]
10. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma.
Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J
Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558
[TBL] [Abstract][Full Text] [Related]
11. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel.
ter Braak B; Siezen CL; Kannegieter N; Koedoot E; van de Water B; van der Laan JW
Arch Toxicol; 2014 Apr; 88(4):953-66. PubMed ID: 24464500
[TBL] [Abstract][Full Text] [Related]
12. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.
Tognon CE; Sorensen PH
Expert Opin Ther Targets; 2012 Jan; 16(1):33-48. PubMed ID: 22239439
[TBL] [Abstract][Full Text] [Related]
13. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
[TBL] [Abstract][Full Text] [Related]
14. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
[TBL] [Abstract][Full Text] [Related]
15. Igf1R/InsR function is required for axon extension and corpus callosum formation.
Jin J; Ravindran P; Di Meo D; Püschel AW
PLoS One; 2019; 14(7):e0219362. PubMed ID: 31318893
[TBL] [Abstract][Full Text] [Related]
16. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A
J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509
[TBL] [Abstract][Full Text] [Related]
18. Imprinted Grb10, encoding growth factor receptor bound protein 10, regulates fetal growth independently of the insulin-like growth factor type 1 receptor (Igf1r) and insulin receptor (Insr) genes.
Moorwood K; Smith FM; Garfield AS; Ward A
BMC Biol; 2024 May; 22(1):127. PubMed ID: 38816743
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
Heidegger I; Kern J; Ofer P; Klocker H; Massoner P
Oncotarget; 2014 May; 5(9):2723-35. PubMed ID: 24809298
[TBL] [Abstract][Full Text] [Related]
20. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
